Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia

 Long-acting injectable antipsychotic treatment options for schizophrenia are part of the treatment plan but what are some of the barriers to their use? Professor John Kane and Dr Charlotte Emborg share their perspectives.

You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
Register for access to Progress in Mind in your country